Your Search Returned 47 tagged news reports
Designed to prevent HAE attacks by inhibition of plasma kallikrein, DX-2930 is a fully human IgG antibody that is currently in a Phase I trial for safety and tolerability profile assessment. Dyax president and CEO Gustav Christensen said entry into
A woman in Germany developed what looked like frostbite on her nose, ears and legs, even though she had not been exposed to extremely cold temperatures, according to a new report of her case. Her skin developed black regions, made up of damaged skin
The technology leverages immunotherapeutic IgE to develop treatment for cancer patients expressing the tumor-associated antigen PSA that is coupled with prostate cancer. The anti-PSA monoclonal IgE demonstrated ability to selectively open the
Multiple Sclerosis drug Tysabri antibodies causing reaction that could have caused death Natalizumab http://www.tysabri.com/?utm_campaign=Branded&utm_source=google&utm_medium=cpc&
Antibodypedia also has the results of approximately 145,000 experiments conducted with the antibodies and 32,000 links to publications related to their use. Antibodypedia co-founder Mathias Uhlen said while Antibodypedia, originally developed with
Here's what's making health news this morning: FDA Grants Approval to Diet Pill From Vivus (WSJ): Approval of Vivus's weight-loss drug Qsymia marks the second approval of a new weight-loss drug in less than a month; the drugs, which require a doctor'
Venom being extracted to make the antivenom serum...Karunakaran Snakebite could very well be India's most neglected tropical disease', says Romulus Whitaker. India has one of the highest rates of death from snakebite in the world.
A UC San Diego exchange student who is facing a more than $100,000 hospital bill for treatment after he was bitten by a rattlesnake spoke with 10News on Tuesday. "My jaw was dropping down," said Dag-Are Trydal, as he described his reaction to the
probably 4 to 5 feet long." "I went around to the other side of the garage door and killed it," Slay said. "He was a pretty healthy looking boy." With temperatures in the 70s and 80s following a wet winter and spring, venomous snakes are making their
The company plans to begin the production by the end of 2012. IGY Immune Technology chief executive officer Terry Dyck said, "The production of IgY at higher purity levels and lower cost will create a number of product development opportunities